The overall inhibition of CaMKII activity can be beneficial in stroke, and CaMKII inhibitors have been proposed as therapeutics promoting neuroprotection in cerebrovascular disease (Deng et al., 2017; Zhang et al., 2021). This evidence concerns the gene CAMK2G and cerebrovascular disorder.